Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1989
Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells
R G Goodwin, S Lupton, A Schmierer, et al.
Science (New York, N.Y.)
|
May 25, 1990
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
C A Smith, T Davis, D Anderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1991
Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells
C F Ware, P D Crowe, T L Vanarsdale, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
K M Mohler, D S Torrance, C A Smith, et al.
The Journal of Experimental Medicine
|
October 7, 1997
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
M A Degli-Esposti, P J Smolak, H Walczak, et al.
The Journal of Experimental Medicine
|
March 1, 1989
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells
P J Morrissey, R G Goodwin, R P Nordan, et al.
Human Genetics
|
July 1, 1989
The gene for human interleukin 7 (IL7) is at 8q12-13
G R Sutherland, E Baker, K E Fernandez, et al.
Cell
|
March 23, 1990
Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily
R G Goodwin, D Friend, S F Ziegler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Functional analysis of TRAIL receptors using monoclonal antibodies
T S Griffith, C T Rauch, P J Smolak, et al.
The Journal of Experimental Medicine
|
January 1, 1995
Fas ligand mediates activation-induced cell death in human T lymphocytes
M R Alderson, T W Tough, T Davis-Smith, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1989
Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells
R G Goodwin, S Lupton, A Schmierer, et al.
Science (New York, N.Y.)
|
May 25, 1990
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
C A Smith, T Davis, D Anderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1991
Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells
C F Ware, P D Crowe, T L Vanarsdale, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
K M Mohler, D S Torrance, C A Smith, et al.
The Journal of Experimental Medicine
|
October 7, 1997
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
M A Degli-Esposti, P J Smolak, H Walczak, et al.
The Journal of Experimental Medicine
|
March 1, 1989
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells
P J Morrissey, R G Goodwin, R P Nordan, et al.
Human Genetics
|
July 1, 1989
The gene for human interleukin 7 (IL7) is at 8q12-13
G R Sutherland, E Baker, K E Fernandez, et al.
Cell
|
March 23, 1990
Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily
R G Goodwin, D Friend, S F Ziegler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Functional analysis of TRAIL receptors using monoclonal antibodies
T S Griffith, C T Rauch, P J Smolak, et al.
The Journal of Experimental Medicine
|
January 1, 1995
Fas ligand mediates activation-induced cell death in human T lymphocytes
M R Alderson, T W Tough, T Davis-Smith, et al.
Page
of 6